Post job

KSQ Therapeutics overview

Industry
Biotechnology
Revenue
Headquarters
Employees
60
Founded in
Organization type
Private
KSQ Therapeutics is pioneering High-Confidence Drug Development: a fundamentally new approach to R&D where the majority of the de-risking work is done prior to the generation of therapeutic drug candidates. Powered by our proprietary CRISPRomics™ drug discovery engine, their team has elucidated the function that each human gene plays in multiple diseases, providing a unique and more comprehensive understanding of disease biology. The quality of these insights enables their scientists to rapidly identify and validate high-confidence, patient-tailored, novel drug targets and then focus their collective efforts on the development of medicines with the greatest potential to impact the lives of patients. KSQ has initiated a pipeline of preclinical discovery programs and was founded in 2015.
The average employee at KSQ Therapeutics makes $46,237 per year. Pay at KSQ Therapeutics is significantly lower than some of its highest paying competitors, like Epizyme, Blueprint Medicines, and Rigel Pharmaceuticals, which pay $86,952, $84,447, and $83,403, respectively.
Based in Cambridge, MA, KSQ Therapeutics is a small health care company with only 60 employees and an annual revenue of $2.6M.

KSQ Therapeutics's mission statement

We systematically discover and pursue the best therapeutic targets for disease intervention, aspiring to the day when cures become the standard of care for patients.

In demand companies are hiring! Let Zippia apply for you!

Floating question marks illustration
-

KSQ Therapeutics employee reviews

Be the first to review!

Do you work at KSQ Therapeutics?

Help job seekers learn about working at KSQ Therapeutics

On this page

Be the first to review KSQ Therapeutics

Anonymously rate your employee experience

Your opinion can help other job seekers

Do you like working at KSQ Therapeutics?

The team at KSQ Therapeutics

  • The founders of KSQ Therapeutics are David Sabatini and Jonathan Weissman.
  • The key people at KSQ Therapeutics are Qasim Rizvi, David Sabatini and Jonathan Weissman.
Key people
Qasim Rizvi
David Sabatini
Jonathan Weissman

KSQ Therapeutics rankings

KSQ Therapeutics is ranked #73 on the Best Start-up companies to work for in Massachusetts list. Zippia's Best Places to Work lists provide unbiased, data-based evaluations of companies. Rankings are based on government and proprietary data on salaries, company financial health, and employee diversity.

Read more about how we rank companies.

KSQ Therapeutics salaries

Average KSQ Therapeutics salary
$46,237
yearly
$22.23 hourly
Updated March 14, 2024

Evaluate KSQ Therapeutics' commitment to diversity and inclusion.

Zippia waving zebra

Do you work at KSQ Therapeutics?

Were you satisfied with KSQ Therapeutics' salary and benefits?

KSQ Therapeutics financial performance

7.9
Performance score

Highest paying KSQ Therapeutics competitors

Compare KSQ Therapeutics salaries to competitors, including Epizyme, Blueprint Medicines, and Rigel Pharmaceuticals. Employees at Epizyme earn the highest average yearly salary of $86,952. The salaries at Blueprint Medicines average $84,447 per year, and the salaries at Rigel Pharmaceuticals come in at $83,403 per year.
RankCompanyAverage salaryJobs
1$86,9520
2$84,4470
3$83,4030
4$82,5410
5$46,1400
6$46,0780

Are you an executive, HR leader, or brand manager at KSQ Therapeutics?

Claiming and updating your company profile on Zippia is free and easy.

KSQ Therapeutics FAQs

Search for jobs

Zippia gives an in-depth look into the details of KSQ Therapeutics, including salaries, political affiliations, employee data, and more, in order to inform job seekers about KSQ Therapeutics. The employee data is based on information from people who have self-reported their past or current employments at KSQ Therapeutics. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by KSQ Therapeutics. The data presented on this page does not represent the view of KSQ Therapeutics and its employees or that of Zippia.

KSQ Therapeutics may also be known as or be related to KSQ Therapeutics, KSQ Therapeutics Inc, KSQ Therapeutics, Inc. and Ksq Therapeutics, Inc.